Clinical Trial Update: 162 mg of Aspirin for Prevention of Preeclampsia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating 162 mg of aspirin for the prevention of preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Methodist Medical Center of Illinois | Conditions: Preeclampsia | Phase 4 | Status: UNKNOWN